Original Research

Published on 07 May 2024

Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Fumihiko Ando
Takeru Kashiwada
Shoko Kuroda
Takenori Fujii
Ryotaro Takano
Yoshishige Miyabe
Shinobu Kunugi
Takashi Sakatani
Akihiko Miyanaga
Tomoko Asatsuma-Okumura

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1384731

1,848 views
1 citation

Original Research

Published on 06 May 2024

Mg-ZIF nanozymes disrupt the level of ROS for osteosarcoma killing via POD activity

in Pharmacology of Anti-Cancer Drugs

Junjie Zheng
Shiqiang Zhuo
Lin Huang
Jinying Wang
Gaofeng Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407989

772 views

Systematic Review

Published on 06 May 2024

Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis

in Pharmacology of Anti-Cancer Drugs

Francisco Cezar Aquino de Moraes
Caroline R. M. Pereira
Vitor Kendi Tsuchiya Sano
Estella Aparecida De Laia
Carlos Stecca
Rommel Mario Rodríguez Burbano

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1352224

1,958 views
4 citations

Review

Published on 06 May 2024

Mechanism and clinical progression of solid tumors bone marrow metastasis

in Pharmacology of Anti-Cancer Drugs

Ruohan Yang
Lin Jia
Jiuwei Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390361

1,240 views

Editorial

Published on 03 May 2024

Editorial: Tumour microenvironment in cancer research and drug discovery

in Pharmacology of Anti-Cancer Drugs

Nur Akmarina B. M. Said
Syed Mahmood
Kenneth K. W. To

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403176

545 views

Original Research

Published on 02 May 2024

Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells

in Pharmacology of Anti-Cancer Drugs

Xuan-Yu Chen
Zhuo-Xun Wu
Jing-Quan Wang
Qiu-Xu Teng
Hailin Tang
Qianwen Liu
Zhe-Sheng Chen
Wenkuan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400699

1,204 views

Brief Research Report

Published on 01 May 2024

Unveiling the anticancer potential of the ethanolic extract from Trichoderma asperelloides

in Pharmacology of Anti-Cancer Drugs

Ana Carolina R. Oliveira
Flávia Santiago De Oliveira
Ana Flávia Bráz
Jamil S. Oliveira
Jane Lima-Santos
Adriana A. M. Dias

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1398135

1,088 views
1 citation

Opinion

Published on 01 May 2024

Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER

in Pharmacology of Anti-Cancer Drugs

Rosamaria Lappano
Marcello Maggiolini
Christophe Mallet
Yves Jacquot

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413058

546 views

Review

Published on 01 May 2024

Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review

in Pharmacology of Anti-Cancer Drugs

Qiang Zhang
Yuting Xia
Feiyan Wang
Dongfeng Yang
Zongsuo Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385565

1,636 views
1 citation

Mini Review

Published on 25 Apr 2024

The combination therapy of oncolytic virotherapy

in Pharmacology of Anti-Cancer Drugs

Yue Wang
Mengying Zhu
Huanyu Chi
Yang Liu
Guilin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380313

1,853 views

Review

Published on 25 Apr 2024

Black phosphorus, an advanced versatile nanoparticles of antitumor, antibacterial and bone regeneration for OS therapy

in Pharmacology of Anti-Cancer Drugs

Lihui Sun
Yu Han
Yao Zhao
Jing Cui
Zhiguo Bi
Shiyu Liao
Zheru Ma
Fengxiang Lou
Chunsheng Xiao
Wei Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396975

1,640 views

Original Research

Published on 24 Apr 2024

Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction

in Pharmacology of Anti-Cancer Drugs

Marwa M. Abu-Serie
Satoru Osuka
Lamiaa A. Heikal
Mohamed Teleb
Assem Barakat
Vikas Dudeja

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363511

2,107 views
2 citations

Mini Review

Published on 24 Apr 2024

The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma

in Pharmacology of Anti-Cancer Drugs

Yi Tang
Maoru Wang
Jiangping Yu
Guangyao Lv
Yu Wang
Bin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395156

1,531 views

Opinion

Published on 23 Apr 2024

Direct antitumor activity of bevacizumab: an overlooked mechanism?

in Pharmacology of Anti-Cancer Drugs

Zhiyong Wang
Jiaqi Li
Jinjin Guo
Pei Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394878

1,669 views

Review

Published on 22 Apr 2024

Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road

in Pharmacology of Anti-Cancer Drugs

Alejandro Ríos-Hoyo
Xavier Monzonís
Joana Vidal
Jenniffer Linares
Clara Montagut

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1398419

2,151 views
1 citation

Original Research

Published on 22 Apr 2024

Role and mechanism of NCAPD3 in promoting malignant behaviors in gastric cancer

in Pharmacology of Anti-Cancer Drugs

Su-Yun Zhang
Qiong Luo
Li-Rong Xiao
Fan Yang
Jian Zhu
Xiang-Qi Chen
Sheng Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341039

1,704 views

Navigation group

Articles

Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer

Mg-ZIF nanozymes disrupt the level of ROS for osteosarcoma killing via POD activity

Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis

Mechanism and clinical progression of solid tumors bone marrow metastasis

Editorial: Tumour microenvironment in cancer research and drug discovery

Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells

Unveiling the anticancer potential of the ethanolic extract from Trichoderma asperelloides

Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER

Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review

The combination therapy of oncolytic virotherapy

Black phosphorus, an advanced versatile nanoparticles of antitumor, antibacterial and bone regeneration for OS therapy

Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction

The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma

Direct antitumor activity of bevacizumab: an overlooked mechanism?

Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road

Role and mechanism of NCAPD3 in promoting malignant behaviors in gastric cancer